Some experimental aspects of cross-resistance between capreomycin and viomycin.
D000995:Antitubercular Agents / Q000009:adverse effects / Q000494:pharmacology*; D002207:Capreomycin / Q000009:adverse effects / Q000494:pharmacology; D004351:Drug Resistance; D006801:Humans; D008826:Microbial Sensitivity Tests; D009169:Mycobacterium tuberculosis / Q000187:drug effects; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy; D014756:Viomycin / Q000494:pharmacology*
D000995:Antitubercular Agents; D002207:Capreomycin; D014756:Viomycin